Cognitive Disorders Clinical Trial
Official title:
A Placebo-controlled, Single-blind, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Drug Interaction of GSK1034702 After Repeat Doses in Healthy Subjects
GSK1034702 is being developed for improving cognitive impairment in diseases such as Alzheimer's disease and schizophrenia. This study will be done in healthy men and women of no child beading potential to investigate repeated doses of the study medicine. The study will investigate the following questions, do repeated doses of the study medicine have any important side effects when taken by mouth? How much of the study medicine gets into the bloodstream, and how quickly does the body get rid of it? Does the study medicine affect memory, attention and problem-solving skills? What are the effects when the study medicine and dextromethorphan are taken together.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
| Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
| Completed |
NCT02342041 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT01659593 -
Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT01561820 -
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
|
N/A | |
| Completed |
NCT00743405 -
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05373394 -
Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
|
||
| Completed |
NCT04860414 -
Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.
|
N/A | |
| Completed |
NCT02324153 -
Ramelteon in the Prevention of Post-operative Delirium
|
Phase 2 | |
| Completed |
NCT00458094 -
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
|
N/A | |
| Completed |
NCT05486195 -
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
|
Phase 1 | |
| Not yet recruiting |
NCT03866018 -
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders
|
N/A | |
| Recruiting |
NCT02876536 -
Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT02321475 -
EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
|
||
| Completed |
NCT01881646 -
Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery
|
Phase 4 | |
| Recruiting |
NCT05888961 -
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
|
N/A | |
| Completed |
NCT01983384 -
Anesthetic Depth and Postoperative Delirium Trial - 2
|
N/A | |
| Completed |
NCT02575482 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00937846 -
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
|
Phase 1 | |
| Completed |
NCT01772095 -
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
|
N/A |